PETER G TRABER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER G TRABER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER G TRABER. PETER G TRABER is a Director in Caladrius Biosciences, Inc. ($NBS) and a Director in TANOX INC ($TNOX) and a President & CEO in GALECTIN THERAPEUTICS INC ($GALT) and a Chief Medical Officer in SELECTA BIOSCIENCES INC ($SELB).
Address: 430 THAMER LANE HOUSTON 77025 TX
Companies in which PETER G TRABER is an Insider
CALADRIUS BIOSCIENCES, INC.
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of PETER G TRABER: Director
Holdings: 83,760 shares
Latest Transaction: Jan 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GALECTIN THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER G TRABER: President & CEO
Holdings: 207,333 shares
Current Value: $263,313
Latest Transaction: Jun 15 2018
$GALT Market Capitalization: $34.39M
$GALT Previous Close: $1.27
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SELECTA BIOSCIENCES INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER G TRABER: Chief Medical Officer
Holdings: 135,500 shares
Latest Transaction: May 27 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TANOX INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER G TRABER: Director
Holdings: 0 shares
Latest Transaction: Jun 06 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PETER G TRABER
Sentiment: All, NBS, GALT, SELB, TNOX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Buy | P | 3.99 | 20,000 | 79,850 | 135,500 | 115.5 K to 135.5 K (+17.32 %) |
| Mar 19 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Buy | P | 4.50 | 10,000 | 45,000 | 98,000 | 88 K to 98 K (+11.36 %) |
| Mar 19 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Buy | P | 4.53 | 10,000 | 45,295 | 88,000 | 78 K to 88 K (+12.82 %) |
| Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | TRABER PETER G | Director | Grant | A | 0.00 | 37,735 | 0 | 83,760 | 46 K to 83.8 K (+81.99 %) |
| Jan 06 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Option Exercise | A | 2.99 | 230,000 | 687,700 | 230,000 | |
| Jan 06 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Grant | A | 0.00 | 38,000 | 0 | 78,000 | 40 K to 78 K (+95.00 %) |
| Jan 06 2021 | SELB | SELECTA BIOSCIENCE ... | TRABER PETER G | Chief Medical Offic ... | Option Exercise | A | 2.99 | 230,000 | 687,700 | 230,000 |